High-dose intensity-modulated radiation therapy as primary treatment of prostate cancer: genitourinary/gastrointestinal toxicity and outcomes, a single-institution experience.
Detti B, Baki M, Becherini C, Saieva C, Scartoni D, Giacomelli I, Trombetta L, Muntoni C, Olmetto E, Francolini G, Turkaj A, Topulli J, Ciabatti C, Carta G, Poggesi L, Delli Paoli C, Terziani F, Grassi R, Livi L.
Detti B, et al. Among authors: carta g.
Radiol Med. 2019 May;124(5):422-431. doi: 10.1007/s11547-018-0977-1. Epub 2019 Jan 3.
Radiol Med. 2019.
PMID: 30607866